Aldagen's proprietary products identify and isolate unique populations of adult stem cells with the potential to revolutionize treatments of cardiovascular disease and degenerative diseases.
Location: United States, North Carolina, Durham
Total raised: $80.65M
Investors 2
| Date | Name | Website |
| - | The Trelys... | trelys.com |
| - | Tall Oaks ... | talloaksca... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 18.01.2012 | - | $645K | - |
| 05.04.2011 | IPO | $80M | - |
Mentions in press and media 16
| Date | Title | Description | Source |
| 16.07.2012 | Stem cell treatment for ischemia, heart failure raises enoug... | Its current funding round should last the business into 2014, he said. Juventas’ competitors include... | medcitynew... |
| 16.05.2012 | Two stem cell therapies from Cytomedix to start trials; stro... | Cytomedix’s goal is to ultimately find large pharmaceutical partners to commercialize these treatmen... | medcitynew... |
| 09.02.2012 | CMXI’s Aldagen acquisition is no exit; stem cell payoff is s... | Aldagen’s “bright cell” technology isolates stem cells that express high levels of the ALDH enzyme, ... | medcitynew... |
| 08.02.2012 | Stem cell therapeutics firm Aldagen acquired by Cytomedix in... | “This strategic acquisition of Aldagen provides Cytomedix with a novel, patent-protected cell select... | medcitynew... |
| 18.01.2012 | Stem cell therapeutics firm Aldagen expands fundraiser to $6... | Venture capital-backed Aldagen has raised more than $60 million from investors that include the Auro... | medcitynew... |
| 03.06.2011 | N.C. Biotech Center names biotech veteran to head western re... | The Biotechnology Center is a private, nonprofit corporation supported by the North Carolina General... | medcitynew... |
| 07.04.2011 | Stem cell firm Aldagen cancels $80 million IPO | Stem cell therapy company Aldagen is pulling back on its plans for an initial public offering. The D... | massdevice... |
| 05.04.2011 | Stem cell therapy firm Aldagen withdraws plans for $80M IPO | Promoted Covid-19’s terrible toll on diabetes patients. What can be done? The public health crisis h... | medcitynew... |
| 13.09.2007 | Life sciences briefing: Thursday, Sept. 13, 2007 | Featured companies: Aldagen, LDR, Lyten Endoscopy, MachLabs, Permatox, TeleMedicine Clinic, ThromboV... | venturebea... |
| - | N.C. Biotech Center names biotech veteran to head western re... | The North Carolina Biotechnology Center has named an executive director to oversee its regional offi... | medcitynew... |
Show more